Listar Producción científica del CEMET por autor "Alonso, Daniel F"

Mostrando ítems 1-2 de 2

In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma

Cardama, Georgina A; Bucci, Paula L; Lemos, Jesús S; Llavona, Candela; Benavente, Micaela A; Hellmén, Eva; Fara, María Laura; Medrano, Eduardo; Spitzer, Eduardo; Demarco, Ignacio A; Sabella, Patricia; Garona, Juan; Alonso, Daniel F (2023-08-03)

Canine mammary carcinomas (CMC) are associated with major aggressive clinical behavior and high mortality. The current standard of care is based on surgical resection, without an established effective ...
Vasopressin Analog [V(4)Q(5)]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models

Sobol, Natasha T; Solerno, Luisina; Llavona, Candela; Alonso, Daniel F; Garona, Juan (2023-12)

Colorectal cancer (CRC) is a leading cause of cancer-associated mortality worldwide. Despite being an essential component of systemic chemotherapy for advanced CRC, 5-fluorouracil (5-FU) clinical use has ...

Mostrando ítems 1-2 de 2

Buscar